Expert picks on key HIV data from CROI 2019, including pre-exposure prophylaxis (PrEP), first-line ART or switch, and treatment during pregnancy
Downloadable slideset from Clinical Care Options on key aspects of HIV PrEP pharmacy service provision, with insights from expert faculty
Post-hoc analysis of DAWNING study at CROI 2019 supports use of dolutegravir-based ART in the presence of NRTI RAMs as reported by Clinical Care Options
Effects of PrEP on drug resistance and acute HIV infection in New York City surveillance population: CROI 2019 conference coverage from CCO
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.